European Heart Journal

List of Contributors

List of Contributors
Eur Heart J 1995 16: ii; doi:10.1093/eurheartj/16.suppl_L.ii [PDF] [Request Permissions]  

Forward

M. L. Simoons

Forward
Eur Heart J 1995 16: 1-2; doi:10.1093/eurheartj/16.suppl_L.1 [PDF] [Request Permissions]  

Atherosclerosis, Plaque Rupture and Thrombosis

Get checked abstract M. J. Davies

Acute coronary thrombosis—the role of plaque disruption and its initiation and prevention
Eur Heart J 1995 16: 3-7; doi:10.1093/eurheartj/16.suppl_L.3 [Abstract] [PDF] [Request Permissions]  

Get checked abstract H. R. Buller and J. W. Ten Cate

Coagulation and platelet activation pathways: A review of the key components and the way in which these can be manipulated
Eur Heart J 1995 16: 8-10; doi:10.1093/eurheartj/16.suppl_L.8 [Abstract] [PDF] [Request Permissions]  

Get checked abstract B. S. Coller

The role of platelets in arterial thrombosis and the rationale for blockade of platelet GPIIb/IIIa receptors as antithrombotic therapy
Eur Heart J 1995 16: 11-15; doi:10.1093/eurheartj/16.suppl_L.11 [Abstract] [PDF] [Request Permissions]  

Get checked abstract M. Verstraete

New developments in antiplatelet and antithrombotic therapy
Eur Heart J 1995 16: 16-23; doi:10.1093/eurheartj/16.suppl_L.16 [Abstract] [PDF] [Request Permissions]  

Risk Assessment for Coronary Intervention

Get checked abstract P. N. Ruygrok, P. P. T. De Jaegere, J. Verploegh, R.T. van Domburg, and P. J. De Feyter

Immediate outcome following coronary angioplasty: A contemporary single centre audit
Eur Heart J 1995 16: 24-29; doi:10.1093/eurheartj/16.suppl_L.24 [Abstract] [PDF] [Request Permissions]  

Get checked abstract N. S. Kleiman

Description of patients undergoing high risk angioplasty: Analyses of various databases
Eur Heart J 1995 16: 30-35; doi:10.1093/eurheartj/16.suppl_L.30 [Abstract] [PDF] [Request Permissions]  

Risk Reduction with Antiplatelet and Antithrombin Therapy

Get checked abstract M. J. B. M. van den Brand, M. L. Simoons, M. J. De Boer, A. van Miltenburg, L. R. van der Wieken, P. J. De Feyter, and The European Cooperative Study Group

Antiplatelet therapy in therapy-resistant unstable angina: A pilot study with REO PRO (c7E3)
Eur Heart J 1995 16: 36-42; doi:10.1093/eurheartj/16.suppl_L.36 [Abstract] [PDF] [Request Permissions]  

Get checked abstract R. M. Califf, A. M. Lincoff, J. E. Tcheng, and E. J. Topol

An overview of the results of the EPIC trial
Eur Heart J 1995 16: 43-49; doi:10.1093/eurheartj/16.suppl_L.43 [Abstract] [PDF] [Request Permissions]  

Get checked abstract E. M. Ohman, R. A. Harrington, A. M. Lincoff, M. M. Kitt, N. S. Kleiman, and J. E. Tcheng

Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor
Eur Heart J 1995 16: 50-55; doi:10.1093/eurheartj/16.suppl_L.50 [Abstract] [PDF] [Request Permissions]  

Get checked abstract J.-P. R. Herrman, R. Simon, V. A. W. M. Umans, P. F. Peerboom, D. Keane, J. J. M. M. Rijnierse, D. Bach, P. Kobi, R. Kerry, P. Close, J. W. Deckers, and P. W. Serruys On Behalf of The Helvetica Study Group

Evaluation of recombinant hirudin (CGP 39 393/^TM REVASC) in the prevention of restenosis after percutaneous transluminal coronary angioplasty: Rationale and design of the HELVETICA trial, a multicentre randomized double blind heparin controlled study
Eur Heart J 1995 16: 56-62; doi:10.1093/eurheartj/16.suppl_L.56 [Abstract] [PDF] [Request Permissions]  

Get checked abstract K.-L. Neuhaus and U. Zeymer

Prevention and management of thrombotic complications during coronary interventions: Combination therapy with antithrombins, antiplatelets, and/or thrombolytics: risks and benefits
Eur Heart J 1995 16: 63-67; doi:10.1093/eurheartj/16.suppl_L.63 [Abstract] [PDF] [Request Permissions]  

Get checked abstract M. L. Knudtson

Clinical management of unstable angina: the place of antithrombins and platelet GP IIb/IIIa receptor blockers
Eur Heart J 1995 16: 68-74; doi:10.1093/eurheartj/16.suppl_L.68 [Abstract] [PDF] [Request Permissions]  

Risks-Benefits-and Cost of Antiplatelet Therapy

Get checked abstract P. W. Armstrong and M. J. Mant

Bleeding risks, risk factors and management of bleeding complications after treatment with anticoagulants, specific antithrombins, thrombolytics IIb-IIIa receptor blockers
Eur Heart J 1995 16: 75-80; doi:10.1093/eurheartj/16.suppl_L.75 [Abstract] [PDF] [Request Permissions]  

Get checked abstract B. A. van Hout and M. L. Simoons

Costs and effects of c7E3 in high risk PTCA patients: An indirect analysis for The Netherlands
Eur Heart J 1995 16: 81-85; doi:10.1093/eurheartj/16.suppl_L.81 [Abstract] [PDF] [Request Permissions]  

A Systematic Approach to Prevention, Detection and Treatment of Thrombotic Complications During Coronary Intervention

Get checked abstract G. Görge, J. Ge, M. Haude, D. Baumgart, G. Caspari, R. Leischik, F. Liu, and R. Erbel

Intravascular ultrasound: a guide for management of complications during intervention?
Eur Heart J 1995 16: 86-92; doi:10.1093/eurheartj/16.suppl_L.86 [Abstract] [PDF] [Request Permissions]  

Get checked abstract H. V. Anderson, R. L. Kirkeeide, J. T. Willerson, R. W. Smalling, and G. Schroth

Coronary artery flow monitoring: The value of intravascular Doppler for detection of complications after interventions
Eur Heart J 1995 16: 93-96; doi:10.1093/eurheartj/16.suppl_L.93 [Abstract] [PDF] [Request Permissions]  

Get checked abstract P. J. De Feyter and P. N. Ruygrok

Coronary intervention: Risk stratification and management of abrupt coronary occlusion
Eur Heart J 1995 16: 97-103; doi:10.1093/eurheartj/16.suppl_L.97 [Abstract] [PDF] [Request Permissions]  

Discussion

Recognition and management of high-risk PTCA procedures
Eur Heart J 1995 16: 104-107; doi:10.1093/eurheartj/16.suppl_L.104 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.